Koninklijke Philips N.V.
PHGHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Koninklijke Philips N.V. focuses on Medical Devices services and products. Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. With a market capitalization of $25.31B, it sits in large-cap territory. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments.
Market Cap
$25.31B
Beta
0.91
P/E (TTM)
19.61
P/E (Fwd)
13.60
EPS (TTM)
$1.32
EPS (Fwd)
$1.90
ROE
10.2%
ROA
4.1%
Cash
$1.79B
Total Debt
$7.46B
Free CF
$1.53B
52W Change
-8.0%
Annual Financials
Cash vs Debt
Where PHG stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, PHG finished 2.06% below its 150-day moving average ($27.13) and 1.85% below its 200-day moving average ($27.07). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PHG overbought or oversold?
At the September 1, 2026 close, PHG's RSI(14) was 43.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Koninklijke Philips N.V. carries $7.46B in total debt against $1.79B in cash reserves — debt is roughly 4.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $1.53B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 10.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $17.16B (2021) to $17.83B (2025).
Investors considering Koninklijke Philips N.V. should weigh the typical risks associated with PHG's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing PHG's risk profile alongside its fundamentals and technical indicators provides a more complete picture.